James Halstead PLC (JHD)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 134.60 |
|---|---|
| 52-week range | 112.00 – 147.60 |
| Return, 1 month / 3 months | +6.5% / +11.8% |
| Return, 1 year / 3 years | +0.6% / −19.4% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 23.6% |
| Worst drawdown (1 year) | -19.2% |
| Average daily value traded | 81.05M GBX |
| Dividend yield | 6.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
James Halstead makes commercial and industrial flooring, sold mainly under the Polyflor name. The company produces vinyl and other resilient floor coverings used in hospitals, schools, shops, offices and other public and commercial buildings. It is based in Manchester in the United Kingdom and supplies customers and distributors in many countries around the world. Its business centres on manufacturing and marketing flooring products rather than installation or retail.
On this site James Halstead PLC appears as a stock on the London Stock Exchange (UK), code JHD, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
James Halstead PLC (JHD) trades on the London Stock Exchange in UK. It last closed at GBX 134.60 on 27 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 509 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.6% and over the last three months it rose 11.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.4% | ||
| From 52-week high | -6.9% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 11.8% | ||
| 6-month return | 0.3% | ||
| 12-month return, skipping the last month | -5.5% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.2% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 81.05M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 86 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.6% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.7% |
|---|---|
| 1 month | +6.5% |
| 3 months | +11.8% |
| 6 months | +0.3% |
| 1 year | +0.6% |
| 3 years | −19.4% |
| 5 years | −38.7% |
Signals
| 50-day / 200-day average | 130.28 / 128.94 |
|---|---|
| Golden / death cross (60 days) | Golden, 14 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Nov 2026 | GBP 0.0610 |
| 7 May 2026 | GBP 0.0285 |
| 13 Nov 2025 | GBP 0.0605 |
| 8 May 2025 | GBP 0.0275 |
| 14 Nov 2024 | GBP 0.0600 |
| 16 May 2024 | GBP 0.0250 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.